144 results
Page 3 of 8
8-K
EX-1.1
za644i be
27 Jun 14
Entry into a Material Definitive Agreement
12:00am
424B5
vew5rjk4lmb8
27 Jun 14
Prospectus supplement for primary offering
12:00am
424B5
8daya5xes7t
24 Jun 14
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
bnrxqjodck pdh
22 Nov 13
Entry into a Material Definitive Agreement
12:00am
424B5
2v19 6m9ypy
21 Nov 13
Prospectus supplement for primary offering
12:00am
424B5
zcsp01tlybx832cp6t
19 Nov 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
5dgiabfnyt 78shkcfao
18 Dec 12
A.P. Pharma Makes Key Appointments in Preparation of Potential FDA Approval of Lead Product Candidate, APF530
12:00am
8-K
EX-99.1
xam6l2eu g7wik9z
14 Dec 12
A.P. Pharma Names Mark S. Gelder, M.D. as Senior Vice President and Chief Medical Officer
12:00am
8-K
EX-10.1
7ahvnu955 pov
25 Jul 12
A.P. Pharma to Raise $53.6 Million in Common Stock Offering
12:00am
CORRESP
ajjx281
27 Jul 11
Correspondence with SEC
12:00am